In a report released yesterday, Stephen Baxter from Wells Fargo maintained a Hold rating on Cardinal Health (CAH – Research Report), with a ...

Cardinal Health, Inc. CAH is scheduled to report fiscal second-quarter 2025 results on Jan. 30, before the opening bell. In ...

Morgan Stanley analyst Erin Wright maintained a Buy rating on Cardinal Health (CAH – Research Report) today and set a price target of $136.00.

sources and distributes Cardinal Health branded medical, surgical, and laboratory products. The company was founded by Robert D. Walter in 1979 and is headquartered in Dublin, OH.

Investors are upbeat about Cardinal Health’s Medical and Pharmaceutical offerings, which provide the company with a ...

Cardinal Health gets downgraded to a hold ... A key risk in this segment is that of regulatory and legal costs involving medical products and drugs. From its profile, what this firm is known ...

Cardinal Health prepares to enter ... at-home healthcare supply business from the former medical segment, renamed Global Medical Products and Distribution; and the $1.2 billion unit manufacturing ...

The company said the new DC will support its at-Home Solutions business and improve the delivery of medical supplies to ...

In addition, it manufactures, sources, and distributes Cardinal Health branded medical, surgical, and laboratory products and devices that include exam and surgical gloves; needles, syringe ...